ARGX - argenx Sotuvning sof marjinal rentabelligi

argenx BVBA (ARGX) korporativ emblemasi va logotipi

argenx SE (ARGX) noyob antitelalardan foydalangan holda autoimmun patologiya terapiyalarini ishlab chiqishda yetakchi hisoblanadi. Toza daromadlilik profili strategiyaning samaradorligini tasdiqlaydi, bunda joriy ko'rsatkich 32.80 ga tengdir. G'arbiy shartnomaviy ishlab chiqarish tashkilotlarining gibrid tarmog'i ishlab chiqarish barqarorligini kafolatlaydi. Past geopolitik risklar va hayotni saqlovchi dori vositalari maqomi kompaniyaning rivojlangan davlatlar bo'ylab barqaror rivojlanishini ta'minlaydi.

argenx SE (ARGX) - Sof marja 04.07.2022dan 19.11.2026gacha

argenx SE (ARGX) boʻyicha keng qamrovli koʻrsatkichlar kesimi va tahlil

- bozor qiymati va tahlilchilarning maqsadli prognozi:
Kompaniyaning jamlanma tahliliyoti:argenx SE
argenx BVBA tayyor mahsulotlari

Sotuv marjalari tushumni sof foydaga aylantirish samaradorligini aks ettiradi va barcha operatsion hamda soliq xarajatlarini qoplashdan keyin qolgan har bir dollar daromadning qismini o'lchaydi. Sof sotuv marjalaridagi tendentsiya argenx SE rahbariyatining moliyaviy intizomini ko'rsatadi, ular tadqiqot va ishlanmalar startapini dori vositalarini joriy etishning yuqori sur'atiga ega bo'lgan tijoriy jihatdan samarali tuzilmaga muvaffaqiyatli aylantira oldilar.

argenx SE (ARGX) raqobatchilari

BNTX: Sotuvning sof marjinal rentabelligi|ABVX (Abivax SA) - Sof marja|Sof marja ADMA Corp|Sof marja Protagonist Therapeutics PTGX|Sof foyda bo'yicha sotuv rentabelligi IMVT (Immunovant Therapeutics)|Kompaniya sotuv marjasi kiniksa.com|Sof marja Grifols Biemat GRFS|Kompaniyaning sof rentabelligi ADPT (Adaptive Biotechnologies Corporation)|celldex.com - Sotuvning sof marjinal rentabelligi|Kompaniya sotuv marjasi Aurinia Pharma AUPH|biocryst.com (BCRX) - Sof marja|Vera Therapeutics, Inc. - Sof foyda normasi|Sof marja Dianthus Therapeutics Inc|Pharvaris NV (PHVS) - Kompaniya sotuv marjasi|Sotuvning sof marjinal rentabelligi ABCL|Tourmaline Corp - Sotuvning sof rentabelligi|Sotuvning sof marjinal rentabelligi PGEN (precigen.com)|Sof foyda bo'yicha marjinallik pharming.com|NKTR - Sof marja|Sof marja Upstream Bio Corp|ZBIO: Sotuvning sof marjinal rentabelligi|Sof foyda bo'yicha sotuv rentabelligi Immunome, Inc.|Sof foyda bo'yicha sotuv rentabelligi GOSS|KALV: Sof foyda normasi|Sotuvning sof marjinal rentabelligi SEPN|Sof foyda bo'yicha sotuv rentabelligi Pieris Pharmaceuticals, Inc. PVLA|Sotuvning sof marjinal rentabelligi SVRA (Savara Inc)|Sotuvning sof marjinal rentabelligi Rigel Pharmaceuticals RIGL|AnaptysBio Inc. - Sotuvning sof marjinal rentabelligi|Astria Therapeutics - Kompaniyaning sof rentabelligi|ENGN: Sotuvning sof marjinal rentabelligi|RAPT - Kompaniya sotuv marjasi|Sof foyda bo'yicha sotuv rentabelligi JBIO|Aclaris (ACRS) - Kompaniya sotuv marjasi|Sotuvning sof marjinal rentabelligi KYTX|Sof foyda bo'yicha sotuv rentabelligi Tiziana Life Sciences TLSA|Sotuvning sof marjinal rentabelligi CABA (cabalettabio.com)|Kompaniyaning sof rentabelligi VTYX (Ventyx Bio)|Theratechnologies, Inc - Sotuvning sof marjinal rentabelligi|AVTX (Avalo Therapeutics Inc.) - Sotuvning sof rentabelligi|eledon.com (ELDN) - Sof marja|Sotuvning sof rentabelligi AGEN|CLYM (climbbio.com) - Sotuvning sof marjinal rentabelligi|Sotuvning sof marjinal rentabelligi zurabio.com|Sof marja aTyr (ATYR)|ADAG - Sof marja|Sof marja ImageneBio Inc IMA|Sotuvning sof marjinal rentabelligi Shattuck Labs, Inc. STTK|EQ - Sof marja|connectbiopharm.com (CNTB) - Sof foyda bo'yicha sotuv rentabelligi|IMUX (Immunic) - Sof foyda bo'yicha sotuv rentabelligi|Atara Biotherapeutics, Inc. - Sof foyda normasi|Sof marja InflaRx|Sof foyda bo'yicha sotuv rentabelligi x4pharma.com (XFOR)|Sotuvning sof marjinal rentabelligi ACET|Sof foyda bo'yicha sotuv rentabelligi Celularity Corp CELU|INmune Bio Inc - Sof foyda bo'yicha sotuv rentabelligi|BRNS (Barinthus Bio) - Sof foyda marjasi|KZR - Sof marja|Kompaniya sotuv marjasi sabbiotherapeutics.com SABS|Akari Therapeutics PLC (AKTX) - Sof marja|ENLV - Kompaniya sotuv marjasi|QTTB (Q32 Bio) - Sotuvning sof marjinal rentabelligi|Sof marja GeoVax Labs Inc GOVX|Sof marja Edesa Biotech (EDSA)|Sof foyda bo'yicha sotuv rentabelligi iBio IBIO|Carisma Therapeutics Inc - Sof foyda bo'yicha sotuv rentabelligi|XTLB - Sof foyda bo'yicha sotuv rentabelligi|BOLT - Sof marja|Sof foyda normasi HCWB (hcwbiologics.com)|APVO: Sotuvning sof marjinal rentabelligi|aimimmuno.com (AIM) - Sotuvning sof marjinal rentabelligi|Sof marja aditxt.com|Sof foyda bo'yicha sotuv rentabelligi GRI Bio Corp (GRI)|Sof marja XORTX Therapeutics Inc. (XRTX)|Sof foyda bo'yicha sotuv rentabelligi ReShape Lifesciences HIND|Sof marja Revelation Biosciences REVB|INDP: Sotuvning sof rentabelligi|SCNI - Sof marja|CALI (calcimedica.com) - Sotuvning sof rentabelligi|AFMD (Affimed Therapeutics) - Sof foyda bo'yicha sotuv rentabelligi|Allakos Therapeutics (ALLK) - Sotuvning sof marjinal rentabelligi|HOOK (HOOKIPA) - Sotuvning sof marjinal rentabelligi|igmbio.com (IGMS) - Kompaniya sotuv marjasi|Sotuvning sof marjinal rentabelligi ITOS|OCEA (Ocean Biomedical) - Sof foyda normasi|Sotuvning sof marjinal rentabelligi TCBP (TC BioPharm (Holdings) PLC)|THRD - Sof foyda bo'yicha sotuv rentabelligi